Global Journal of Medical Research, F: Diseases, Volume 23 Issue 2

© 2023. Vladimir N. Pak. This research/review article is distributed under the terms of the Attribution-NonCommercial- NoDerivatives 4.0 International (CC BY-NC-ND 4.0). You must give appropriate credit to authors and reference this article if parts of the article are reproduced in any manner. Applicable licensing terms are at https://creativecommons.org/licenses/by-nc- nd/4.0/. A Cancer Prevention and Treatment Opportunity By Vladimir N. Pak Abstract- Cancer disease results from mutations leading to apoptosis failure and immune system dysfunction. Because one in two people in developed counties will be diagnosed with cancer in their lifetimes, cancer and metastasis prevention should be ahead of therapies. The immune system in cancer patients is compromised and can be fixed with a reboot. The major oncofetal protein – alpha-fetoprotein – can deliver toxins instead of nutrients to the immune suppressor cells and kill them. The death of myeloid suppressor cells unleashes the immune attack on cancer cells, cancer stem cells, and metastases. Injectable and oral formulations of alpha- fetoprotein with toxins provide an opportunity to prevent and treat the disease. Keywords: alpha-fetoprotein, myeloid suppressor cells, cancer prevention, metastases, cancer stem cell, immunotherapy, NK cell. GJMR-F Classification: DDC Code: 616.99406 LCC Code: RC271.A62 ACancerPreventionandTreatmentOpportunity Strictly as per the compliance and regulations of: Global Journal of Medical Research: F Diseases Volume 23 Issue 2 Version 1.0 Year 2023 Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Online ISSN: 2249-4618 & Print ISSN: 0975-5888